Because CRP is an acute-phase protein that enters the circulation in response to tissue damage and inflammation and can be a biological marker of chronic systemic inflammation, moderate increases in CRP levels are associated with an increased risk of CRC [5,[21], [22], [23], [24], [25]]. This evidence concerns the gene CRP and colorectal carcinoma.